Author:
Adams Hugo J. A.,Kwee Thomas C.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference10 articles.
1. Barrington SF, Johnson PW (2017) FDG PET-CT in lymphoma: has imaging-directed personalized medicine become a reality? J Nucl Med 58(10):1539–1544.
https://doi.org/10.2967/jnumed.116.181347
2. Yamane T, Daimaru O, Ito S, Yoshiya K, Nagata T, Ito S, Uchida H (2004) Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas. J Nucl Med 45(11):1838–1842
3. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33(11):1972–1980
4. Brepoels L, Stroobants S, Verhoef G, De Groot T, Mortelmans L, De Wolf-Peeters C (2009) (18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model. J Nucl Med 50(7):1102–1109.
https://doi.org/10.2967/jnumed.109.062208
5. Brepoels L, De Saint-Hubert M, Stroobants S, Verhoef G, Balzarini J, Mortelmans L, Mottaghy FM (2010) Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET. Eur J Nucl Med Mol Imaging 37(9):1688–1695.
https://doi.org/10.1007/s00259-010-1479-0